Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × Endosonography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 2 Neoplasms 2 Platelet Glycoprotein IV Deficiency 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Cyst 1 Neoplasm Metastasis 1 Fatty Liver 1 Disease 1 Cysts 1 Adenocarcinoma 1

Interventions

pembrolizumab 46 Specimen Handling 30 Magnetic Resonance Spectroscopy 27 Biopsy 26 Radiosurgery 19 Gemcitabine 14 Nivolumab 13 Cisplatin 13 Paclitaxel 11 Carboplatin 11 Cyclophosphamide 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Fluorouracil 9 Capecitabine 9 Oxaliplatin 8 Drug Therapy 8 Doxorubicin 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Radiotherapy 7 olaparib 6 cemiplimab 6 abemaciclib 6 Standard of Care 6 Folfox protocol 6 Docetaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831136 2025-09-10

PANCARDINAL-2

The University of Texas Health Science Center, Houston

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡